Table 1.
Cell cycle phases, ploidy index, and DNA fragmentation at prostate adenocarcinoma, benign prostatic hyperplasia, and non-malignant adjacent tissue samples.
| Number | Parameters | Control X ± SD |
PCa X ± SD |
Control X ± SD |
BPH X ± SD |
|---|---|---|---|---|---|
| 1 | G0/G1 phase | 68.67 ± 1.51 | 76.84 ± 20.68 | 68.67 ± 1.51 | 66.74 ± 34.38 |
| p values | 0.14 | 0.86 | |||
| 2 | S phase | 10.23 ± 0.43 ** | 4.32 ± 4.91 ** | 10.23 ± 0.43 ** | 2.35 ± 1.37 ** |
| p values | 0.00 | 0.00 | |||
| 3 | G2/M phase | 14.64 ± 2.99 | 8.81 ± 14.23 | 14.64 ± 2.99 | 20.42 ± 33.03 |
| p values | 0.19 | 0.60 | |||
| 4 | DNA index | 1.00 ± 0.01 * | 1.38 ± 0.51 * | 1.00 ± 0.01 * | 1.19 ± 0.20 * |
| p values | 0.01 | 0.03 | |||
| 5 | subG0/G1 | 1.43 ± 0.11 * | 4.63 ± 2.69 * | 1.43 ± 0.11 | 2.19 ± 2.74 |
| p values | 0.01 | 0.40 | |||
Legend: X, obtained results mean; SD, standard deviation; PCa, prostate adenocarcinoma; BPH, benign prostatic hyperplasia; ** p ≤ 0.01 and * p < 0.05 represent statistically significant differences between controls and experimental samples made by independent t test.